Clinical Trials Browser

Completed × Lymphoma, Non-Hodgkin × pixantrone × Clear all

NCT02499003 2022-03-31

GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma

Phase 2 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT01321541 2021-11-19

PIX-R

Phase 3 Completed

312 enrolled 16 charts

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01491841 2020-03-04

BRP

Phase 1 Completed

33 enrolled 13 charts

Lymphoma, Non-Hodgkin

NCT00088530 2020-02-05

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

Phase 3 Completed

140 enrolled 15 charts

Lymphoma, Non-Hodgkin

NCT00060684 2015-01-19

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Phase 1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell